Evidence map›Paper›PMID 30908665›Full record

ArticleAlcoholism, clinical and experimental research2019

Protective Effects of Facilitated Removal of Blood Alcohol and Acetaldehyde Against Liver Injury in Animal Models Fed Alcohol and Anti-HIV Drugs.

Hui Han, Yuxin He, Heather Johnson, Pratibha Mishra, Harrison Lee, Cheng Ji

Open access · greenAbstract readComparative Study
In one paragraph

Article in Alcoholism, clinical and experimental research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Hui HanDepartment of Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
Yuxin HeDepartment of Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
Heather JohnsonDepartment of Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
Pratibha MishraDepartment of Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
Harrison LeeDepartment of Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
Cheng JiDepartment of Medicine, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.ORCID 0000-0002-6725-1803
University of Southern California · US

Funding

USC RESEARCH CENTER FOR LIVER DISEASES: PILOT PROGRAMSP30DK048522 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI OOKHTENS, MURAD · 1995 to 2020
$21.8M
Primary role of Golgi stress in anti-HIV drug and alcohol abuse-induced hepatotoxicityR01DA042632 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JI, CHENG · 2017 to 2021
$2.1M
Nanocapsules that decompose alcohol as antidotes for alcohol intoxication.R21AA023952 · NIAAA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JI, CHENG · 2015 to 2016
$417k
NIAAA NIH HHS R21 AA023952NIDA NIH HHS R01 DA042632NIDDK NIH HHS P30 DK048522U.S. National Institute of Health (NIH) R01DA042632
6 · The paper itself

Abstract

backgroundWe previously developed enzyme nanoparticles (ENP) of alcohol metabolism. This study was to evaluate protective effects of facilitated removal of blood alcohol and/or acetaldehyde on anti-HIV drugs and alcohol-induced liver injuries.

methodsENP were prepared for degrading alcohol completely (ENP1) or partially into acetaldehyde (ENP2), which were applied to mice of acute binge or chronic-binge alcohol feeding in the presence of antivirals (ritonavir and lopinavir). Liver pathologies were examined to assess the protective effects of ENP.

resultsIn the acute model, ENP1 and ENP2 reduced the blood alcohol concentration (BAC) by 41 and 32%, respectively, within 4 hr, whereas in control without ENP, BAC was reduced only by 15%. Blood acetaldehyde concentration (BADC) was increased by 39% in alcohol-fed mice treated with ENP2 comparing to control. No significant effects of the anti-HIV drugs on BAC or BADC were observed. Plasma alanine aminotransferase (ALT) and expression of liver TNF-α were both significantly increased in the alcohol-fed mice, which were normalized by ENP1. In the presence of the antivirals, ALT was partially reduced by ENP1 or ENP2. In the chronic model, inflammation, fatty liver, and ALT were increased, which were deteriorated by the antivirals. ENP1 partially reduced BAC, BADC, ALT, and expression of inflammation markers of TNF-α, F4/80, and IL-6 and lipogenic factors of ACC, LXRα, and SREBP1. ENP2 reduced BAC without significant effects on ALT, inflammation, or lipogenesis. Antivirals and alcohol synergistically increased expression of organelle stress markers of CHOP, sXBP-1, ATF6, and GCP60. ENP1 reduced BAC, CHOP, and sXbp-1. However, no effects of ENP1 were found on ATF6 or GCP60.

conclusionsRemoval of blood alcohol and acetaldehyde by the ENP protects the liver against alcoholic injuries, and the protection is less effective in chronic alcohol and antiviral feeding due to additional drug-induced organelle stresses.

Indexed as

AcetaldehydeAlcohol OxidoreductasesAldehyde DehydrogenaseAnimalsAnti-HIV AgentsCatalaseDrug Evaluation, PreclinicalEthanolLiver Diseases, AlcoholicMaleMice, Inbred C57BLNanoparticlesAcetaldehydealcohol oxidaseAlcohol OxidoreductasesAldehyde DehydrogenaseAnti-HIV AgentsCatalaseEthanolDrug/Alcohol AbuseEnzyme NanoparticlesLiver InjuryOrganelle StressTreatment of Alcohol Intoxication

Identifiers

PMID30908665
PMCPMC6551258
OpenAlexW2943724167

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.